Four batches of GlucaGen HypoKit recalled

Novo Nordisk is recalling four batches of GlucaGen HypoKit in Australia.The GlucaGen HypoKit is indicated for the treatment of severe hypoglycaemic reactions (low blood sugar) which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents.Novo Nordisk conducted an investigation showing a small number (0.006%) of needles were detached from the